Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › nicotinamide riboside

nicotinamide riboside

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of nicotinamide riboside

3 trials tracked of nicotinamide riboside: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 2 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2
  1. Phase 3 Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease Completed · 2 cited
  2. Phase 2 Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection Completed
  3. Phase 2 Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
NAD+ repletion via NMN or NR shows context-dependent effects on muscle stem cell homeostasis and sarcopenia
Nutrition & Obesity Medicine Sys. Review
NAD+ repletion via NMN or NR shows context-dependent effects on muscle stem cell homeostasis and sarcopenia NAD+ boosters may help muscle stem cells fight aging weakness
This systematic review synthesizes nearly 60 representative preclinical and clinical studies on NAD+ repletion for sarcopenia. The authors d…
A review of nearly 60 studies suggests NAD+ precursors like NMN or NR could support muscle stem cells and reduce oxidative stress in sarcope…
Frontiers Jun 5, 2026
Nicotinamide Riboside Plus Exercise Improves Fitness in Friedreich's Ataxia
Pediatrics RCT
Nicotinamide Riboside Plus Exercise Improves Fitness in Friedreich's Ataxia Combining exercise and nicotinamide riboside improved fitness in Friedreich's ataxia patients
This phase 2 randomized trial in 66 individuals with Friedreich's ataxia found that 12 weeks of nicotinamide riboside plus exercise increase…
A 12-week trial found that combining exercise with nicotinamide riboside improved heart and lung fitness in people with Friedreich's ataxia.
May 1, 2026
Nicotinamide riboside and NAD+ injections show preliminary safety in healthy participants
Drug Pipeline RCT
Nicotinamide riboside and NAD+ injections show preliminary safety in healthy participants Nicotinamide Riboside Injections Are Safe But Cause Mild Pain
This Phase 1 RCT in healthy participants assessed bolus injections of nicotinamide riboside or NAD+. The study found 100% participant retent…
New injection data shows Nicotinamide Riboside is safe but causes mild pain and soreness for most people.
medRxiv May 1, 2026